HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TheraCIM

a recombinant humanized antibody against the Epidermal Growth Factor receptor (EGF-R) for cancer therapy
Also Known As:
TheraCIM hR3
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Spicer, James: 1 article (04/2005)
2. Selman-Housein, Guillermo: 1 article (01/2005)
3. Mateo, Cristina: 1 article (01/2005)
4. Triguero, Ada: 1 article (01/2005)
5. Gavilondo, Jorge V: 1 article (01/2005)
6. Ayala, Marta: 1 article (01/2005)
7. Freyre, Freya: 1 article (01/2005)
8. Pérez, Lincidio: 1 article (01/2005)
9. Pujol, Merardo: 1 article (01/2005)
10. Ramírez, Nadia I: 1 article (01/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Epidermal Growth Factor Receptor (EGF Receptor)
2. Epidermal Growth Factor (EGF)
3. nimotuzumab
4. monoclonal antibody 99mTc-hR3